February 4-8, 2017
Philip Gribbon represented EU-OPENSCREEN here.
Kathy Skopelitou will represent EU-OPENSCREEN at the symposium which is organised by our Greek EU-OPENSCREEN partners at the Aristotle University of Thessaloniki. Researchers from academia and industry are invited to participate and discuss about the current status of Chemical Libraries in Europe and future challenges regarding the organization, function and contribution of Chemical Libraries in Research and Economic Development.
Oct 1-2nd, 2019, Heidelberg, Germany
Tanja Miletic (Project Manager) and Martin Neuenschwander (Compound Logistics Manager) will represent EU-OPENSCREEN at the meeting.
CORBEL is an initiative of thirteen biological and medical research infrastructures (BMS RIs), which together will create a platform for harmonised user access to biological and medical technologies, biological samples and data services required by cutting-edge biomedical research. Scientists who benefit from transnational open access to dedicated technology platforms through CORBEL will present their project's progress. Their presentations will be complemented by the technology providers from partner sites from research infrastructures giving their view on the project. Not only this meeting will help to advance the individual projects through face-to-face discussions and networking between different technology platforms and external users. The goal of this meeting is also to unveil and subsequently address bottlenecks in the implementation and transition of projects from one research infrastructure to the next.
October 28-30, 2019 Paris, France
Wolfgang Fecke will give a keynote at this conference. For more information visit the conference website.
Nov 5-6, 2019 Liverpool, UK
Do not miss Tanja Miletic´s poster presentation on EU-OPENSCREEN at the ELRIG "Looking back to future conference" in Liverpool, UK. For more information visit the conference website.
Nov 6-8, 2019 La Palma, Canary Islands
Wolfgang Fecke will represent EU-OPENSCREEN at this meeting to explore key issues that emerged through the roadmap process.
Dec 7-11, Washington DC, USA
Do not miss the talk of our Scientific Strategy Officer, Bahne Stechmann, on "How to boost your research project with the support of inernational research infrastructures" at ASCB/EMBO on Tuesday Dec 10, 2019 at 10.00 in theater 4, Exhibit Hall. More information can be found here.
Sep 26, 2019, Maceió, Brasil
Bahne Stechmann will give a presentation on "EU-OPENSCREEN - An International Research Infrastructure initiative to facilitate Chemical Biology and early Drug Discovery" at the 51st Congress of SBFTE (Brazilian Society of Pharmacology and Experimental Therapeutics, in Maceió on September 26th.
The presentation is part of the Symposium on 'Main Challenges for Innovation in Pharmacology'. The theme of the congress is 'Challenging frontiers in Pharmacology' and 600-700 scientists, including graduate students and postdocs, will attend. The presentation aims to initiate new collaborations with Brazilian researchers and is part of EU-OPENSCREEN's initiative to build new partnerships with Latin American countries.
The presentation will explain how assay providers from Brazil can use the EU-OPENSCREEN compound collection to develop, in collaboration with EU-OPENSCREEN partner sites, novel chemical probes, and how Brazilian chemists and pharmacologists can collaborate with EU-OPENSCREEN to identify biological activities of their compounds.
For more info see here.
Sep 25-28, 2019, Poznan, Poland
Wolfgang Fecke (EU-OPENSCREEN Director General) will represent EU-OPENSCREEN at the conference. Jacek Kolanowski from our local Partnersite, the Institute of Bioorganic Chemistry (IBCH) at the Polish Academy of Sciences, will give an up-date on the activities within the EU-Horizon 2020 grant, EU-OPENSCREEN DRIVE, which enhances the sustainability and operational excellence of EU-OPENCREEN and its services. Attendees will also have the opportunity to visit the EU-OPENSCREEN Partner Site Institute of Bioorganic Chemistry (IBCH).
ICBB2019 is co-organized by our EU-OPENSCREEN screening partner site, the Institute of Bioorganic Chemistry, Polish Academy of Sciences, Asia-Pacific Association of Science, Engineering and Technology, Adam Mickiewicz University, and Chinese Journal of Biologicals, in collaboration with multiple academic affiliations.
More info here.
Sep 25, Brussels, Belgium
Wolfgang Fecke will represent EU-OPENSCREEN at this meeting of Top Roadmap Stakeholders in Brussels.
Sep 9-12th, 2019, Basel, Switzerland
BASEL LIFE is Europe’s leading congress in the Life Sciences, showcasing cutting-edge science and technology, and more than 2,000 participants are expected. If you attend the BASEL LIFE Miptec 2019 in Basel on September 9-12, stop by at our booth 'European Research Infrastructures', which is organized by EU-OPENSCREEN (represented by our European Relations and Grant Officer Dr. Katja Herzog) and Instruct-ERIC.
EU-OPENSCREEN offers open-access to a network of partner sites throughout Europe who work in Chemical Biology and early Drug Discovery. As a research infrastructure, EU-OPENSCREEN collaborates with international scientists from academia and industry to facilitate research in early Drug Discovery. Instruct-ERIC offers open-access to a wide range of high end structural biology technologies across Europe, such as cryo-Electron microscopy, NMR, x-ray diffraction and mass spectrometry, as well as training and internships. Discuss with us how you can use these valuable resources to address your research questions.
More info here.
Sep 8-11, 2019, Istanbul, Turkey
Meet and discuss with Bahne Stechmann at the Asian Federation for Medicinal Chemistry (AFMC) 12th International Symposium 'New Avenues for Design and Development of Translational Medicine' in Istanbul on September 8-11th .
EU-OPENSCREEN offers international medicinal and organic chemists the opportunity to profile their compounds and integrate them into the EU-OPENSCREEN academic compound collection, which will be screened by EU-OPENSREEN's partner sites and thereby uncovers the biological activities of these compounds. Thanks to EU-OPENSCREEN's pan-European network of partner sites, the compounds will be tested in a large number of screens, and thereby exposed to a wide range of biological targets.
Bahne will present the poster 'EU-OPENSCREEN - Innovative collaboration models in early drug discovery'.
For more information see here.
July 8-11, 2019 University of the Basque Country, Vitoria-Gasteiz (Spain)
On July 8 at 09:35-09:50 in room OC-11, Jordi Quintana will give a talk on “EU-OPENSCREEN drive: building the European academic chemical library”. For more information see here.
July 6-11th 2019, Krakow, Poland
Bahne Stechmann (EU-OPENSCREEN Scientific Strategy Manager) will be present at the meeting.
The FEBS Congress has become a unique collaboration between FEBS and its Constituent Societies (the biochemistry and molecular biology societies across Europe and neighbouring regions that belong to FEBS), with the organization of the event awarded to a different host Society each year. While the event retains the core elements that make it 'The FEBS Congress' (under the guidance of FEBS), this approach enables each host Society to bring a local flavour and fresh ideas to the meeting, and also gives opportunities for participants to explore new locations. Although always taking place in the FEBS area, the FEBS Congress attracts scientists from across the globe, and you do not need to be a member of a FEBS Constituent Society to take part.
More infos here.
June 19th, 2019, Rehovot, Israel
Wolfgang Fecke (EU-OPENSCREEN Director General) will represent EU-OPENSCREEN with a booth at the Weizmann Institute of Science.
More infos here.
26-28 June, 2019, Barcelona, Spain
The EU-OPENSCREEN partner site Fundacion MEDINA will be presenting the recent innovations at the SLAS Europe Meeting in Barcelona from June 26-28. The Head of Screening and Target Validation, Francisca Vicente, will be speaking about implementations of HTS in Natural Products in the Labcyte Tutorial: “Beyond Small Molecule Screening with the Echo® Liquid Handlers and Access™ Workstations” on Thurs June 27th at 8:30 a.m. in Room 118.
More and more researchers are applying innovative technologies beyond the world of small molecules in the search for novel therapeutic targets and therapies. Presentations from LifeArc, Fundación MEDINA, and University Hospital of Zurich will discuss about implementations using the Echo® Liquid Handlers and the Access™ Workstation for high-throughput screening of fragments, natural products, and antibodies. In addition, the Principal Scientist, Carmen Ramos, will be presenting the poster entitled “P069-Spheroids 3D culture, a powerful tool in Drug Discovery screening in cancer research” on Thurs June 27th at 1:15 pm.
Cancer is a leading cause of death worldwide in spite of numerous efforts made in anticancer drug discovery. One of the reasons is the inefficient drug discovery models using a classic 2D cell culture, since it cannot recreate in vivo conditions.
For this reason, 3D tumor cell culturing has emerged to more closely simulate these conditions. In order to evaluate the cytotoxicity of potential antitumor drugs, MEDINA has included two approaches based on spheroids culture: the high-throughput method for measuring viability assays, and an image-based assay with three-dye staining method (calcein AM, propidium iodide and Hoechst) which provides insight into the mechanism of cytotoxicity. By applying this method, it is possible to distinguish active compounds that kill tumor cells within the spheroid, other compounds that disintegrate the spheroid/tumor, and others that reduce the spheroid size. These findings increase the value of the active compound discovered.
Sona Gurska from the High throughput screening and High content analysis core at our EU-OPENSCREEN partner site in Olomouc, Poland, (Univerzita Palackeho V Olomouci) and Jana Kotulova, both under the leadership of Petr Džubák, are presenting a poster (No 91) with the title "A high-throughput, whole cell-based assay for cytotoxicity profiling of new chemical compounds".
For more information on SLAS Europe 2019 see here.
June 11-12th, 2019, Berlin, Germany
Wolfgang Fecke (EU-OPENSCREEN Director General) and Tanja Miletic (Project Manager) will be present at the Drug Discovery Summit.
The R&D Europe Series unites over 400 drug discovery attendees from global pharmaceutical organisations, top biotech companies and internationally renowned academic institutions specialising in various therapeutic areas. This renowned series of events provide a valuable opportunity for leaders to transform and lead the future of drug discovery and development.
An invaluable resource for those looking to improve efficiency, increase pipelines and keep up to date with the latest advances. Looking at small molecules and biologics, this congress will feature key insights into protein degradation, AI/ML in drug discovery and provide updates in screening and modelling including CRISPR and organ-on-a-chip techniques. Key therapeutic areas include: immunotherapy and oncology.
Bringing you the latest in discovery enabling technologies, computational based drug design and discovery chemistry, this congress bring together leading figures in the field to discuss the evolving techniques being utilised in the sector. Key focus areas include; DNA encoded libraries, protein-protein interactions, AI/ML in drug design and medicinal chemistry for oncology.
Companies at the forefront of this field, including Amgen, Genentech, F star, Merus and Numab will present their insights on bispecific drug discoveries using the novel applications and engineering technologies as well as bispecific therapeutic development beyond immune-oncology. Key focus areas include developability, immunogenicity, safety and CMC considerations to bring bispecifics into the clinic successfully.
The Congress will bring together a host of key experts from this new and exciting field, examining the latest advances in neuroscience research, both in target identification & validation-led approaches. Case Studies will include a focus on the tools & technologies enabling novel treatment developments, critical biomarker & translational work in preclinical development, alongside an overview of the current and ongoing successful collaborative models of research between the pharmaceutical industry and clinical institutions.
Drug discovery agenda here.
Other agendas (Neuroscience, Bispecific, Discovery Chemistry) can be requested through this website.
More infos here.
May 22nd-24th 2019, Madrid (Alcalá de Henares), Spain
Katja Herzog will attend the conference with a booth and represent the CORBEL project there as well.
The 4th Instruct Biennial Structural Biology Conference will take place in Alcalá de Henares, Spain, from May 22 till May 24, 2019. The historical Alcalá de Henares was the original location of the Universidad Complutense, founded in 1293 and one of the oldest universities in the world, as well as being the birthplace of Miguel de Cervantes. The social programme of the meeting will include a visit to the city, a gala dinner and extensive opportunities to network with the Instruct Structural Biology community.
More infos here.
May 22-23rd, 2019, Gothenburg, Sweden
The third ELRIG meeting on Advances in Cell Based Profiling in Drug Discovery will be held at the AstraZeneca R&D premises in Gothenburg. This interactive 2-day event will host leading scientists from academia and industry to discuss current and future formats for cell based assays. This time the bi-annual meeting will be accompanied by a satellite meeting on Chemical Biology on May 24th, organized by our EU-OPENSCREEN collaborators from the Chemical Biology Consorium Sweden (CBCS) and other academic infrastructures in the Nordic countries. The aim is to create an open and inspiring environment for networking between biologists and chemists, working towards a common view on expectations from our cell assays and their use for target identification, target validation and compound profiling purposes.
Plenary Keynote Speakers: Herbert Waldmann (Max Planck Institute of Molecular Physiology, Dortmund, Olli Kallioniemi (SciLifeLab, KI, Stockholm), Ulli Elling (Institute of Molecular Biotechnology, IMBA, Vienna), Craig Crews (Yale University).
Cell based assays are utilized at all stages of drug discovery to explore disease mechanisms and to identify novel molecular therapeutics. Significant advancements are being made towards cell reagents and formats that provide a more accurate biological context, aiming at improving translation to human physiology/pathophysiology. Their implementation is much needed for improving success rates in drug discovery, but there are significant challenges associated with reliable and affordable reagent supply and validation of improved translational power to justify costs. This meeting serves to explore recent advancements and to discuss their practical implementation in drug and chemical probe discovery and validation.
More infos here.
May 7th, 2019, Berlin, Germany
Philip Brennecke (Scientific Project Officer) will represent EU-OPENSCREEN at the meeting.
BIONNALE is the biggest networking event for life sciences and healthcare industries in the German capital region. Representatives from academia and industry attend the annual life sciences event in Berlin to identify, engage and start strategic relationships. The networking character is one strength of BIONNALE with more than 900 attendees from over 20 countries in the last year.
More infos here. #BIONNALE
April 10th, 2019, Berlin, Germany
Jens von Kries and research team, Marc Nazare and research team (EU-OPENSCREEN partner site FMP-FVB), Wolfgang Fecke, Ronald Frank and Katja Herzog (EU-OPENSCREEN) were present at the meeting.
This year, the symposium will highlight the latest developments in the field of small molecules. Two international key notes, Hana Algül from the Klinikum rechts der Isar der Technischen Universität München and Stefano Piccolo from the University of Padova, Italy, will present their work. Further experts from industry and academia will present their current projects and challenges. A poster session in the afternoon break and a get-together in the evening will provide plenty of time for networking.
Program and more infos here.
April 6-9th 2019, Orlando, FL, US
Bahne Stechmann (EU-OPENSCREEN) was present at the meeting and presented a poster on acccess opportunities for scientific user projects within EU-OPENSCREEN.
Break ground on new discoveries. The 2019 ASBMB Annual Meeting is where leading experts and scientists at all points on their career trajectories convene to share new research. It’s your chance to go beyond your everyday routine and discuss your work with influencers in your specialty. Attend inspiring lectures and hands-on workshops, connect with peers in the biochemistry and molecular biology community, and gain inspiration to take back to the lab. Join us at the pinnacle of scientific exchange April 6–9 in Orlando.
More infos here.
April, 3rd-5th in Madrid, Spain
EU-OPENSCREEN ERIC is co-organiser and the whole team will be there to meet you!
Chemical biologists from all parts of Europe and overseas come together to present and discuss the latest achievements in cutting edge chemical sciences. This present joint meeting gathers researchers from organic & biological chemistry, proteins biotechnology, computational biology, protocells, machine learning, bacterial resistance, drug discovery, synthetic biology, biomedical materials and chemical glycobiology. We encourage young researchers to present their work at the meeting (oral & flash presentations will be selected from abstracts), discuss with the speakers and embrace the exciting developments currently happening in chemical biology.
More infos on the conference here.
March 14th-15th 2019, Berlin, Germany
Katja Herzog (EU-OPENSCREEN) will present a poster on the access models to EU-OPENSCREEN services.
The Novel Antimicrobials and AMR Diagnostics 2019 conference is a platform for SMEs, start-ups, big pharma, academia, investors and public institutions to discuss strategies and the specific challenges faced by SMEs in bringing new antimicrobial treatments and diagnostics to the market.
More infos here.
March 11-12, Berlin, Germany
Edgar Specker (FMP Berlin) and Bahne Stechmann (EU-OPENSCREEN) will present the concept of EU-OPENSCREEN and outline the compound management operation at the FMP and EU-OPENSCREEN at the 'Working in Partnership' session of the SLAS 2019 European Sample Management Symposium.
More information here.
Tuesday, February 5th, 4.30-5pm in Washington, USA
Dr. Wolfgang Fecke, director of EU-OPENSCREEN ERIC, will give the talk "A novel European Compound Screening Library for EU-OPENSCREEN" in the "Small molecule libraries" session/podium discussion at the SLAS 2019 in Washington, USA. Looking forward to meeting you there!
Location at conference: 146C
Meet EU-OPENSCREEN (Dr. Katja Herzog) at the Berlin Science Week.
ATTENTION: Event language will be German.
FUTURE 4.0 THE FUTURE WILL BE GOOD. BECAUSE WE MAKE IT!
Ladies and Gentlemen, Let us shape the future together. We therefore invite you to the Berlin Science Week - to our event Future 4.0: Work, Products, Locations on 8 November 2018, 15:00 o'clock - 21:00 o'clock to the Technical University of Berlin (Lichthof in the main building, Straße des 17. Juni 135, 10623 Berlin)
Get to know Berlin's places of the future and meet interesting companies that will shape the products of the future with you. Get in touch with scientific institutions that will also put your ideas of tomorrow into practice. Find out about the places where all the knowledge and skills come together.
We would like to draw your special attention to two highlights:
Keynote lecture: "What does theory say: How will we work in the future? In which areas will our working environments change?" Prof. Dr. Hoppe, Humboldt University Berlin
Panel discussion: "What does a modern future location have and need? Participants: Jutta Heim-Wenzler (Tempelhof Projetion GmbH), Corinna Huge (Senate Administration for Economics, Energy and Business), Dr. Christina Quensel (Campus Berlin-Buch GmbH), Roland Sillmann (WISTA Management GmbH), Thomas Henn (VIRTENIO GmbH), Moderation: Ingo Hoppe
We are looking forward to seeing you!
Ljubljana, Slovenia, September 2-6, 2018
Philip Brennecke will present EU-OPENSCREEN in Ljubljana. For more information see here: www.ldorganisation.com/v2/produits.php
Vienna, Austria, September 12-14, 2018
Wolfgang Fecke will represent EU-OPENSCREEN in Vienna. For more information see here: www.icri2018.at
San Diego, USA, December 8-12, 2018
Bahne Stechmann will present EU-OPENSCREEN in San Diego. For more information see here: ascb-embo2018.ascb.org/symposia/
Prague, Czech Republic, July 7-12, 2018
Bahne Stechmann (EU-OPENSCREEN) and Naomi Gray (INSTRUCT) are jointly organising the session "European Research Infrastructures: Find your collaboration partner in structural biology and chemical biology" at the 43rd FEBS 2018 Congress in Prague. Find out how you can benefit from services provided by Instruct-ERIC and EU-OPENSCREEN ERIC, and hear two interesting examples of recent research from leading scientists using these technologies: Dr Jan Dohnálek, Group leader at the Biotechnology and Biomedicine Center of the Academy of Sciences and Charles University in Vestec (BIOCEV) will present his NMR based studies at the Instruct-ERIC centre on Zn-dependent nucleases from plants, fungi and bacterial pathogens. Dr Petr Bartunek, Director of CZ-OPENSCREEN, the National Infrastructure for Chemical Biology, and Group leader at the Institute of Molecular Genetics at Academy of Sciences in Prague will present the Czech infrastructure for Chemical Biology and explain how external biologists can collaboratively develop their own probes by using the state-of-the-art facilities within CZ-OPENSCREEN.
Recent in-silico approaches will be discussed as well as their applications in academic drug discovery efforts including drug repurposing and high-throughput combinatorial approaches to guide the biologist to select appropriate high-quality probes for their experiments.
For more information: 2018.febscongress.org
Berlin, Germany, July 7-11, 2018
EU-OPENSCREEN is jointly organising with Euro-BioImaging and INSTRUCT the networking session "New Horizons in Neuroscience: Solving membrane protein structures; biological and medical imaging; and high throughput drug screening". This session is a unique opportunity to network with other neuroscientists and find out about opportunities to benefit from free training and research visits to high end laboratories across Europe offering access to the latest technologies including cryo-Electron Microscopy, Xray spectroscopy, NMR, Nanobody discovery, selective plane illumination microscopy (SPIM), super resolution microscopy, multi-modal molecular imaging and high throughput drug screen technologies.
Professor Radu Aricescu from the University of Cambridge will present his latest research in the area of GABA receptor structure and function allowing fresh insights into inhibitory neurotransmission. He will share his experience in working with European research infrastructures and how open access to high-end technologies can enable cross-disciplinary, pioneering research projects.
For more information, please see here.
San Diego, USA, April 21-25, 2018
'CORBEL', a Horizon 2020-funded initiative of eleven biomedical research infrastructures, launched a call for collaborative research projects, which generated a lot of interest among European scientists and over 20 projects have been accepted. As CORBEL will launch a second call for projects in early 2018, Bahne Stechmann will highlight the success of the first CORBEL call and the research opportunities that research infrastructures represent to molecular biologists and biochemists at the annual meeting of the ASBMB.
Loutraki, Greece, March 21-24, 2018
EU-OPENSCREEN is a member of the Horizon 2020-funded project 'CORBEL' which enables complex research projects that require the expertise and technologies of several research infrastructures. Bahne Stechmann will present CORBEL at the European Cystic Fibrosis Society (ECFS) Basic Science Conference to illustrate these new research opportunities to the cystic fibrosis community.
FESTO, Esslingen (Stuttgart), February 28, 2018
Philip Gribbon will represent EU-OPENSCREEN at the ELRIG Meeting on "Robotics & Automation" in Esslingen, Germany.
January 30-31, 2018
Katja Herzog and Philip Gribbon will represent EU-OPENSCREEN at the DECHEMA Meeting "Advances in Chemical Biology" in Frankfurt, Germany.
EU-OPENSCREEN, together with Euro-BioImaging and INSTRUCT, organises a session on "New Opportunities for Researchers – Open Access to Transnational Research Infrastructures in Imaging, Structural Biology, and Compound Screening" at the upcoming EMBO-ASCB Conference. The session will take place on Sunday, 11:00-12:00 am. Bahne Stechmann presents EU-OPENSCREEN.
Bahne Stechmann will give a presentation on EU-OPENSCREEN during a Special Session on the "Global chemical biology landscape" at the upcoming International Chemical Biology Sympoisum (ICBS) on Thursday, October 19th.
Katja Herzog will represent EU-OPENSCREEN at the SIBS 2017 Congess in Zurich.
Prague, Czech Republic
Katja Herzog will represent EU-OPENSCREEN at the Translational Medicine 2017 EATRIS Conference in Prague.
Bahne Stechmann will give an early bird session on "New European research infrastructures in imaging, structural biology and compound screening: how to take advantage as a researcher? ".
Bahne Stechmann will represent EU-OPENSCREEN.
Katja Herzog and Bahne Stechmann will represent EU-OPENSCREEN.
Brno, Czech Republic
Bahne Stechmann will represent EU-OPENSCREEN.
Maren Kappe will represent EU-OPENSCREEN.
June 6-7, 2017
The Conference Chair will be our Danish EU-OPENSCREEN partner Mads Clausen. Numerous other EU-OPENSCREEN partners such as Per-Anders Enquist (Umea University), Anna-Lena Gustafsson (CBCS), Jeanette Hammer Andersen (Tromso University), Krister Wennerberg (FIMM) and our coordinator Philip Gribbon will participate in the scientific committee and the meeting.
June 20, 2017
Katja Herzog will represent EU-OPENSCREEN at this event.
July 2-4, 2017
The ECBS 2017 is organised by our Hungarian EU-OPENSCREEN partners Attila Reményi and György Dormán and many other EU-OPENSCREEN partners will be joining the conference. Philip Gribbon from the EU-OPENSCREEN head office will participate here.
March 14-15, 2017
Philip Gribbon and Bahne Stechmann represented EU-OPENSCREEN here.
March 6-7, 2017
Edgar Specker, Head of Compound Management, Medicinal Chemistry Group, FMP Leibniz Institute for Molecular Pharmacology presented on "Structure Based Drug Design of Tryptophan Hydroxylase (TPH) Inhibitors Exploiting the Binding Pocket of the Co-Substrate Pterin".
Tel Aviv, Israel
February 13-14, 2017
Haim Barr represented EU-OPENSCREEN here.
February 4-8, 2017
Philip Gribbon represented EU-OPENSCREEN here.
Berlin, Germany, June 27-29, 2016
Project Coordinator Philip Gribbon presented EU-OPENSCREEN at the MACUMBA conference focusing on the biotechnical application of marine microbes in Berlin Adlershof.
Madison, USA, October 24-26, 2016
Project Coordinator Philip Gribbon presented EU-OPENSCREEN at ICBS 2016 in Madison, Wisconsin, US
Berlin, Germany, April 12-13, 2016
Project coordinator Philip Gribbon presented EU-OPENSCREEN at the SLAS Conference on Compound Management in Industry and Academia in Berlin, Germany.